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Exploring the feasibility of engaging Traditional 
Birth Attendants in a prevention of Mother to Child 
HIV Transmission program in Lilongwe, Malawi
   Abstract
Objective
To investigate the willingness of  Traditional Birth Attendants (TBAs) to 
provide single dose antiretroviral prophylaxis to infants born to mothers 
with HIV and the feasibility of  providing the TBAs with antiretroviral 
medication.
Design 




TBAs were recruited by local health workers and participated in focus 
groups assessing their attitudes towards participation in a PMTCT 
program.
Results 
TBAs were willing to participate in this prevention of  mother-to-child 
HIV transmission (PMTCT) program and helped identify barriers to their 
participation. 
Conclusions 
Given appropriate support and training, TBAs’ participation in PMTCT 
programs could be an additional way to deliver medication to mothers and 
neonates who might otherwise miss crucial doses of  medication.  
Introduction
The burden of  HIV is seen most acutely in Sub-Saharan 
Africa where 90% of  HIV infected children reside.  In 
Malawi, the prevalence among people between ages 14 and 
59 is 11%1. Amongst pregnant women prevalence of  up to 
17% is seen in urban areas2.  Given the number of  infants 
potentially exposed at childbirth, PMTCT is both significant 
and preventable.  Without treatment, as many as 14-45% of  
infants can become infected with HIV during labor, delivery 
and breastfeeding3.  In Malawi, almost 50% of  pregnant 
women deliver outside the hospital with a TBA4 despite 
HIV positive women being strongly advised to present to 
the hospital for delivery.  Ensuring that HIV-positive women 
and their newborn infants receive single dose antiretroviral 
prophylaxis by TBAs is imperative to the overall success of  
prevention of  mother-to-child HIV transmission (PMTCT) 
programs5.  The Malawi PMTCT 2002 guidelines, in place at 
the time of  this study, were based on single-dose nevirapine 
prophylaxis, with the mother taking a dose at the onset of  
labor and the infant receiving a dose within 72 hours of  
delivery.  A woman determined to be HIV positive is given 
her dose of  nevirapine at the first antenatal visit.  The 
infant’s dose is dispensed at the hospital following delivery. 
Following this research study, Malawi has adopted Option 
B+ of  the WHO recommendations that provide all HIV 
positive women with 3 antiretroviral drugs for life.  While this 
is the ideal treatment for women, uptake will not be 100% 
and women will continue to deliver outside the hospital with 
TBAs, making their involvement in PMTCT still relevant. 
Materials and Methods
We conducted two focus groups in June 2007 with 17 
registered, practicing TBAs in Lilongwe, Malawi. Active 
TBAs were contacted by local health workers and invited to 
participate in the focus groups.  By creating a story about 
a hypothetical HIV positive woman presenting to the TBA 
in labor, the groups discussed TBA practices, willingness 
and barriers to, and support needed for, participation in a 
PMTCT program.  The focus groups were conducted in 
Chichewa, the local language and led by a trained Malawian 
researcher. The focus groups were audio recorded, translated 
into English and transcribed for analysis.  The two focus 
group sessions were then compared and prevailing themes 
identified using ATLAS.ti software for analysis.  
Results
The average time in TBA practice was 13 years. The majority 
learned their birthing skills from their mother.  Nearly half  
of  the TBAs had no formal education and only one TBA 
considered herself  literate in written Chichewa.  
TBAs identified structural barriers to delivering single 
dose antiretroviral prophylaxis including lack of  training 
in administration of  the medication and lack of  adequate 
governmental support for their practice.  The women 
highlighted their perceived lack of  support by describing 
the acute need for supplies.  Specifically the TBAs noted 
the need for soap, gloves, masks, aprons, clean water, shoes 
and cloth for swaddling newborns.  Those who complete 
the governmental training are given delivery kits however 
they note the supplies are not adequate for the number 
of  deliveries performed.  This lack of  personal protective 
equipment places TBAs at risk when participating in 
deliveries of  HIV positive women.
The focus group participants stated they know where to look 
for the HIV status of  the laboring woman in the woman’s 
health passport and if  positive they look for the antiretroviral 
prophylaxis in her bag.  They voiced frustration at not having 
the medication to provide if  the HIV positive woman arrived 
in labor without it.
Perceived barriers also focused on interactions with the 
laboring women, specifically women’s fear of  side effects of  
the medication for themselves and their newborn.  Another 
important barrier was disclosure of  HIV status by the woman 
to the TBA.  Many women feared being forced to deliver 
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in the hospital, the current policy for HIV-positive women 
in labor, and would potentially hide their status as a way to 
deliver with the TBA.  TBAs felt they could utilize their close 
relationship with laboring women to improve uptake of  the 
single dose antiretroviral prophylaxis; a pregnant woman 
would be likely to trust the advice of  her TBA to use the 
medication. 
The TBAs did not feel that documentation of  their work 
would be difficult as they are already in the practice of  using 
pictorial records for charting.  TBAs requested institutional 
support in the form of  official sanction from the Malawian 
Ministry of  Health, PMTCT training and better equipped 
birthing kits as well as a clearer identification symbol of  HIV 
status on the health card.
Discussion
 TBAs in Malawi expressed universal willingness to participate 
in a PMTCT program with administration of  single dose 
antiretroviral prophylaxis.  Although therapy has changed 
from sd NVP to lifetime ARV therapy, TBA involvement 
in the PMTCT process may improve maternal and infant 
outcomes through promotion of  ART medication in the 
critical peri-partum period.  With official support, provision 
of  supplies, adequate training and a clear method to identify 
HIV infected women, the involvement of  TBAs in a PMTCT 
program is feasible.  
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